• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A call for greater policy and regulatory coherence for an expanding menu of legal psychoactive substances.

作者信息

Fischer Benedikt, Bullen Chris, Hall Wayne

机构信息

School of Population Health, University of Auckland, Auckland, New Zealand.

School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.

出版信息

Drug Alcohol Rev. 2020 Sep;39(6):737-742. doi: 10.1111/dar.13071. Epub 2020 May 18.

DOI:10.1111/dar.13071
PMID:32420658
Abstract
摘要

相似文献

1
A call for greater policy and regulatory coherence for an expanding menu of legal psychoactive substances.呼吁针对不断增加的合法精神活性物质种类实现更强的政策和监管一致性。
Drug Alcohol Rev. 2020 Sep;39(6):737-742. doi: 10.1111/dar.13071. Epub 2020 May 18.
2
New Zealand's review of the Psychoactive Substances Act 2013: a missed learning opportunity ahead of the national cannabis law reform referendum?新西兰对2013年《精神活性物质法》的审查：在全国大麻法律改革公投之前错失的学习机会？
Addiction. 2019 Jun;114(6):1129-1130. doi: 10.1111/add.14589. Epub 2019 Mar 20.
3
Understanding the development of a regulated market approach to new psychoactive substances (NPS) in New Zealand using Punctuated Equilibrium Theory.运用间断平衡理论理解新西兰对新型精神活性物质进行管制性市场管理的发展。
Addiction. 2018 Nov;113(11):2132-2139. doi: 10.1111/add.14260. Epub 2018 Jun 8.
4
The challenge of a ban on animal testing for the development of a regulated legal market for new psychoactive substances (NPS) ('legal highs') in New Zealand: Issues and options for resolution.在新西兰，为发展受监管的新精神活性物质（NPS）（“合法快感”）市场而禁止动物试验面临的挑战：解决问题的要点和方案。
Int J Drug Policy. 2015 Dec;26(12):1273-8. doi: 10.1016/j.drugpo.2015.08.006. Epub 2015 Aug 20.
5
New Psychoactive Substances: Evolution in the Exchange of Information and Innovative Legal Responses in the European Union.新型精神活性物质：欧盟信息交流和创新法律应对的演变。
Int J Environ Res Public Health. 2020 Nov 23;17(22):8704. doi: 10.3390/ijerph17228704.
6
New psychoactive substances in Taiwan: challenges and strategies.台湾的新型精神活性物质：挑战与策略。
Curr Opin Psychiatry. 2020 Jul;33(4):306-311. doi: 10.1097/YCO.0000000000000604.
7
A critical examination of the definition of 'psychoactive effect' in Australian drug legislation.对澳大利亚毒品立法中“精神活性作用”定义的批判性审视。
Int J Drug Policy. 2017 Feb;40:16-25. doi: 10.1016/j.drugpo.2016.10.002. Epub 2016 Nov 21.
8
The New Zealand Psychoactive Substances Act (PSA): a policy breakthrough or just a symbolic act?新西兰《精神活性物质法》（PSA）：政策突破还是只是象征性举动？
Addiction. 2014 Oct;109(10):1590-1. doi: 10.1111/add.12541.
9
High prevalence of quasi-legal psychoactive substance use among male patients in HIV care in Japan: a cross-sectional study.日本接受艾滋病病毒治疗的男性患者中准合法精神活性物质使用率高：一项横断面研究。
Subst Abuse Treat Prev Policy. 2017 Feb 23;12(1):11. doi: 10.1186/s13011-017-0097-2.
10
Thirty-one psychoactive plants exempted from New Zealand's Psychoactive Substances Act 2013.31种精神活性植物被新西兰2013年《精神活性物质法》豁免。
Addiction. 2017 Jan;112(1):181-182. doi: 10.1111/add.13526. Epub 2016 Aug 23.

引用本文的文献

1
Germany's evolving framework for cannabis legalization and regulation: Select comments based on science and policy experiences for public health.德国不断演变的大麻合法化及监管框架：基于科学与公共卫生政策经验的若干评论
Lancet Reg Health Eur. 2022 Nov 14;23:100546. doi: 10.1016/j.lanepe.2022.100546. eCollection 2022 Dec.
2
Facing the option for the legalisation of cannabis use and supply in New Zealand: An overview of relevant evidence, concepts and considerations.面对新西兰大麻使用和供应合法化的选择：相关证据、概念和考虑因素概述。
Drug Alcohol Rev. 2020 Jul;39(5):555-567. doi: 10.1111/dar.13087. Epub 2020 May 20.